Similar Items: Do Pharmaceutical Companies Profit from the Covid19 Crisis?
- The Impacts of Pharmaceutical Companies on Economic Recovery after COVID-19
- The Impact of Innovation on the Profitability of Slovak Pharmaceutical Companies
- Exit Routes, Investor Type, and the Covid-19 Crisis: Insights From UK Equity-Funded Companies
- Financial Volatility and Investment Dynamics in the Pharmaceutical Sector: Evidence from the Covid-19 Pandemic
- First Impacts of the Covid19 Crisis on Economic Growth in Central and Eastern European Countries (from Forecasts to Reality)
- Accelerated Knowledge Exchange in Times of Crisis – Lessons from COVID-19 Pandemic